Duration of IPV Priming and Antibody Decay

PHASE4CompletedINTERVENTIONAL
Enrollment

1,645

Participants

Timeline

Start Date

November 5, 2017

Primary Completion Date

October 1, 2019

Study Completion Date

October 1, 2019

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Bivalent oral poliovirus vaccine (bOPV) at 6,10 and 14 weeks of age

bOPV at 6, 10 and 14 weeks of age

BIOLOGICAL

Inactivated poliovirus vaccine (IPV) at 14 weeks and 18 months of age

IPV at 14 weeks and 18 months of age

BIOLOGICAL

Inactivated poliovirus vaccine (IPV) at 14 weeks, 18 weeks and 18 months of age

IPV at 14 weeks, 18 weeks and 18 months of age

BIOLOGICAL

Inactivated poliovirus vaccine (IPV) at 14 weeks and 9 months of age

IPV at 14 weeks and 9 months of age

BIOLOGICAL

Inactivated poliovirus vaccine (IPV) at 6 weeks and 9 months of age

IPV at 6 weeks and 9 months of age

BIOLOGICAL

Inactivated poliovirus vaccine (IPV) at 6 and 14 weeks of age

IPV at 6 and 14 weeks of age

Trial Locations (2)

Unknown

International Center for Diarrhoeal Disease Research, Bangladesh, Dhaka

Mirpur clinic (International Center for Diarrhoeal Disease Research, Bangladesh), Dhaka

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

Centers for Disease Control and Prevention

FED

NCT03202719 - Duration of IPV Priming and Antibody Decay | Biotech Hunter | Biotech Hunter